Larson Financial Group’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.9K Buy
1,491
+1,021
+217% +$45.8K ﹤0.01% 1161
2025
Q4
$14.9K Buy
470
+90
+24% +$2.81K ﹤0.01% 1883
2025
Q3
$10.7K Buy
380
+130
+52% +$3.94K ﹤0.01% 1981
2025
Q2
$9.2K Sell
250
-32
-11% -$1.11K ﹤0.01% 1850
2025
Q1
$11.1K Buy
282
+32
+13% +$1.44K ﹤0.01% 1594
2024
Q4
$11.6K Sell
250
-26
-9% -$1.18K ﹤0.01% 1431
2024
Q3
$12.5K Buy
276
+26
+10% +$1.24K ﹤0.01% 1387
2024
Q2
$12.3K Buy
+250
New +$10.2K ﹤0.01% 1202
2023
Q2
Sell
-18
Closed -$271 1627
2023
Q1
$271 Hold
18
﹤0.01% 1455
2022
Q4
$429 Hold
18
﹤0.01% 1385
2022
Q3
$1K Hold
18
﹤0.01% 1256
2022
Q2
$1K Hold
18
﹤0.01% 1155
2022
Q1
$1K Sell
18
-200
-92% -$11.1K ﹤0.01% 1005
2021
Q4
$17K Buy
218
+200
+1,111% +$20.5K ﹤0.01% 584
2021
Q3
$2K Hold
18
﹤0.01% 800
2021
Q2
$2K Buy
+18
New +$2.09K ﹤0.01% 740

Other funds holding TWST

Larson Financial Group's TWST Position: Q1 2026 in Review

Larson Financial Group increased its Twist Bioscience (TWST) stake by 217% in Q1 2026, buying an estimated $45.8K and bringing the position to 1,491 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

Larson Financial Group first reported a position in TWST in Q2 2021 and has held it in 16 quarters since. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Larson Financial Group held 1,491 shares of Twist Bioscience worth $70.9K as of Q1 2026.
  • Larson Financial Group bought 1,021 Twist Bioscience shares in Q1 2026, an estimated $45.8K.
  • Twist Bioscience made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1161 holding.
  • Larson Financial Group first reported a position in Twist Bioscience in Q2 2021 and has held it in 16 quarters since.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.